369 related articles for article (PubMed ID: 7295075)
1. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
[TBL] [Abstract][Full Text] [Related]
2. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
Jørstad S; Smeby LC; Widerøe TE; Berg KJ
Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
[TBL] [Abstract][Full Text] [Related]
3. Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenerating haemofiltrate using a newly developed system.
Jörstad S; Smeby LC; Wideröe TE; Berg KJ
Proc Eur Dial Transplant Assoc; 1979; 16():212-7. PubMed ID: 548983
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of middle molecules: clinical evaluation using a selective filtration artificial kidney.
Jörstad S; Smeby LC; Wideröe TE
Artif Organs; 1981; 4 Suppl():98-103. PubMed ID: 7295103
[TBL] [Abstract][Full Text] [Related]
5. [Uremic middle-molecule toxins and their removal in hemofiltration].
Kazakov IV; Timokhov VS
Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
[No Abstract] [Full Text] [Related]
6. Design analyses of a new selective filtration system for removal of uremic toxins.
Smeby LC; Jørstad S; Wilderøe TE
Clin Nephrol; 1980 Mar; 13(3):125-32. PubMed ID: 7379362
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
Bourgoignie J; Klahr S; Bricker NS
J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
[TBL] [Abstract][Full Text] [Related]
8. Concentration of plasma middle molecular weight substances and clinical condition of patients undergoing short-time regular dialysis treatment.
Válek A; Dzúrik R; Spustová V; Válková D
Artif Organs; 1981; 4 Suppl():173-6. PubMed ID: 7295088
[TBL] [Abstract][Full Text] [Related]
9. Uremic toxins: a new focus on an old subject.
Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
[TBL] [Abstract][Full Text] [Related]
10. The effect of hemodialysis on endogenous middle molecules in uremic patients.
Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
[TBL] [Abstract][Full Text] [Related]
11. [Uremic toxins. Mechanisms of excretion, diffusibility through membranes and rate of storage].
Nesse AB; Arrizurieta de Muchnik E
Medicina (B Aires); 1984; 44(2):127-36. PubMed ID: 6537453
[No Abstract] [Full Text] [Related]
12. A bench to bedside view of uremic toxins.
Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
[TBL] [Abstract][Full Text] [Related]
13. Transport of uremic toxins through conventional hemodialysis membranes.
Jörstad S; Smeby LC; Wideröe TE; Berg KJ
Clin Nephrol; 1979 Oct; 12(4):168-73. PubMed ID: 509791
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and clinical evidence for uremic toxicity.
Bouré T; Vanholder R
Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
[TBL] [Abstract][Full Text] [Related]
15. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
Thomas G; Jaber BL
Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Renal handling of middle molecules in uremic patients and in the isolated rat kidney.
Lustenberger N; Schindhelm K; Nordmeyer C; Schurek HJ; Stolte H
Artif Organs; 1981; 4 Suppl():110-4. PubMed ID: 7295076
[TBL] [Abstract][Full Text] [Related]
18. Large-scale isolation of middle and higher molecular weight uremic toxins.
Brunner H; Mann H; Essers U; Byrne T
Artif Organs; 1981; 4 Suppl():41-5. PubMed ID: 7295094
[TBL] [Abstract][Full Text] [Related]
19. Should dialysis modalities be designed to remove specific uremic toxins?
Baurmeister U; Vienken J; Ward RA
Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
[TBL] [Abstract][Full Text] [Related]
20. Uremic blood cleansing by diafiltration using a hollow fiber ultrafilter.
Henderson LW; Ford C; Colton CK; Bluemle LW; Bixler HJ
Trans Am Soc Artif Intern Organs; 1970; 16():107-12. PubMed ID: 5460441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
